OFIX Share Price

Open 38.25 Change Price %
High 39.17 1 Day 0.59 1.54
Low 37.95 1 Week 1.32 3.51
Close 38.89 1 Month 1.82 4.91
Volume 159936 1 Year 0.14 0.36
52 Week High 48.25
52 Week Low 35.61
OFIX Important Levels
Resistance 2 40.02
Resistance 1 39.55
Pivot 38.67
Support 1 38.23
Support 2 37.76
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
ETRM 0.07 40.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.66 1.08%
MU 20.66 1.08%
More..
NASDAQ USA Top Gainers Stocks
SSH 0.58 176.19%
SSH 0.58 176.19%
SSH 0.58 176.19%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
MBLX 0.51 64.52%
COOL 5.17 63.61%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
SHIP 1.20 -45.45%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Orthofix International N.V. (NASDAQ: OFIX)

OFIX Technical Analysis 3
As on 8th Dec 2016 OFIX Share Price closed @ 38.89 and we RECOMMEND Sell for LONG-TERM with Stoploss of 41.68 & Sell for SHORT-TERM with Stoploss of 39.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
OFIX Target for December
1st Target up-side 39.47
2nd Target up-side 40.73
3rd Target up-side 41.99
1st Target down-side 35.87
2nd Target down-side 34.61
3rd Target down-side 33.35
OFIX Other Details
Segment EQ
Market Capital 768761152.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.orthofix.com
OFIX Address
OFIX
7 Abraham De Veerstraat
Cura,
Netherlands Antilles
Phone: 599 9 465 8525
Fax: 599 9 461 6978
Interactive Technical Analysis Chart Orthofix International N.V. ( OFIX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Orthofix International N.V.
OFIX Business Profile
Orthofix International N.V. (Orthofix) is a diversified, global medical device company focused on developing and delivering repair and regenerative solutions to the spine and orthopedic markets. The Company operates in two global business units, which include Spine and Orthopedics. It designs, develops, manufactures, markets and distributes medical equipment used principally by musculoskeletal medical specialists for spine and orthopedic applications. Its main products are spinal implant products and related human cellular and tissue based products (HCT/P products) used in surgical procedures, non-invasive regenerative stimulation products used to enhance bone growth and the success rate of spinal fusions and to treat non-union fractures, external and internal fixation devices used in fracture repair, limb lengthening and bone reconstruction.